#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic kidney disease Neonatal alloimmune thrombocytopenia Hepatic cirrhosis Epstein-Barr virus associated lymphoproliferative disorder Burkitt's lymphoma refractory Angiosarcoma non-metastatic Cardiac failure acute Philadelphia chromosome positive Hereditary optic atrophy Pleural mesothelioma Complex regional pain syndrome Mucous membrane pemphigoid Congenital cystic kidney disease Nephrotic syndrome Essential thrombocythaemia More trials…

    Learn about Rare Diseases

    Leiomyosarcoma recurrent – Treatment Pemphigoid – Treatment SAPHO syndrome – Diagnostics Marginal zone lymphoma refractory – Treatment Toxic epidermal necrolysis Combined immunodeficiency Arterial tortuosity syndrome – Life with Disease Burkitt’s lymphoma – Trials in Disease Angiosarcoma non-metastatic – Basic Information Synovial sarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tirzepatide Lisinopril IMB 101 Leniolisib Phosphate Chlortalidone Regn7257 Kd050 HYDROMORPHONE HYDROCHLORIDE Beclometasone Dipropionate Vosilasarm Ebastine Mva-209-Fsp-B4 Quizartinib Dihydrochloride Poa Pratensis Pollen Extract Lenzumestrocel MAGNESIUM CARBONATE HEAVY Cefaclor Sertraline Brexpiprazole Alnuctamab More therapies…

    Learn about Your Condition

    Erosive oesophagitis Atrial fibrillation Autoimmune disorder Neutropenia Systemic infection Vesicoureteric reflux Myeloid leukaemia Phaeochromocytoma Liposarcoma Follicular thyroid cancer Circulatory collapse Gastrectomy Scoliosis Rubella Herpes simplex More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Istituto Oncologico Veneto

Istituto Oncologico Veneto

Via Gattamelata 64, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Retifanlimab Alone and in Combination with Drug Therapy for Adults with Advanced or Metastatic Endometrial Cancer Who Have Not Responded to Platinum Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer metastatic
    • Endometrial cancer
    Investigated Drugs:
    • Human Igg1K Monoclonal Antibody Against Tim-3
    • Tuparstobart
    • Pemigatinib
    Belgium France Greece Italy

  • Study on the Safety and Effectiveness of Pembrolizumab, Vibostolimab, and Lenvatinib for Patients with PD-1 Refractory Melanoma

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Quavonlimab
    • Vibostolimab
    • Lenvatinib
    France Italy

  • Study of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Belgium Ireland Italy The Netherlands Portugal Spain

  • Study of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Adagrasib
    • Ramucirumab
    • Aflibercept
    Austria Belgium Czechia Denmark Finland France +9

  • Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Infliximab
    Belgium Denmark France Germany Italy The Netherlands +3

  • Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Newly Diagnosed Limited-Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • Olaparib
    • Etoposide
    • Carboplatin
    Belgium Bulgaria Estonia France Greece Hungary +5

  • Study Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cisplatin
    • Gemcitabine
    • Pembrolizumab
    Bulgaria Croatia Czechia France Germany Greece +6

  • Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Relatlimab
    • Nivolumab
    • Regorafenib
    Austria Belgium Czechia France Germany Italy +4

  • Study of Pembrolizumab, Trastuzumab, and Chemotherapy for Patients with HER2 Positive Advanced Stomach or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    France Germany Ireland Italy Poland Spain

  • Study on the Safety and Tolerability of TransCon IL-2 β/γ, Pembrolizumab, and Chemotherapy in Adults with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Acp-017
    • Transcon Il-2Β/Γ
    • Pembrolizumab
    Belgium Italy Poland Spain
Previous Page
1 … 36 37 38 39 40 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!